Novo Nordisk A/S vs PPG Industries, Inc. — how do they compare? Novo Nordisk A/S trades at $45.9 (market cap $207.85B), while PPG Industries, Inc. trades at $115.82 (market cap $25.82B). The key difference: Novo Nordisk A/S is far larger — about 8× PPG Industries, Inc.'s market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| NVO | PPG | |
|---|---|---|
Market Cap | $207.85B | $25.82B |
Sector | Health | Basic Materials |
52-Week High | $63.98 | $131.56 |
52-Week Low | $35.29 | $94.34 |
Enterprise Value | $222.55B | $31.69B |
Dividend Yield | 3.81% | 2.55% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →